Steroids: Too Little Too Late in COVID-19 Respiratory IllnessTo this day, the Infectious Disease Society of America and the National Institutes of Health Guidelines do not advise prehospital use of corticosteroids in COVID-19 illness.
Conversely oral and or nebulized steroids have been a part of the FLCCC and McCullough protocols since 2020. Justification for early steroids sadly comes from an autopsy study of fatal cases by Kato et al who evaluated 61 cases from the NIH, Cornell, and University of North Carolina Chapel Hill.
Kato T, Asakura T, Edwards CE, Dang H, Mikami Y, Okuda K, Chen G, Sun L, Gilmore RC, Hawkins P, De la Cruz G, Cooley MR, Bailey AB, Hewitt SM, Chertow DS, Borczuk AC, Salvatore S, Martinez FJ, Thorne LB, Askin FB, Ehre C, Randell SH, O’Neal WK, Baric RS, Boucher RC. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1336-1352. doi: 10.1164/rccm.202111-2606OC. PMID: 35816430.n…
The bottom line is that after 20 days, SARS-CoV-2 is gone from the trachea and the big problem is mucus plugging and congestion.Within the small blood vessels of the lungs, blood clots are forming. Kato showed the only factor associated with reduced mucus in these fatal cases was dexamethasone most commonly used at 6 mg a day in the IDSA and NIH protocols....
Source: Steroids: Too Little Too Late in COVID-19 Respiratory Illness (https://www.theepochtimes.com/health/steroids-too-little-too-late-in-covid-19-respiratory-illness_4923178.html)